| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/22/2007 | US20070041941 Nucleic acid sequences encoding and compositions comrpising ige signal peptide and/or il-15 and methods for using the same |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/22/2007 | US20070041901 2'-O-methyl substituted nucleic acids specific to prostate specific membrane antigen (PSMA) for use in detection and targeting cancer tissues |
| 02/22/2007 | CA2619763A1 Fas binding antibodies |
| 02/22/2007 | CA2619725A1 Single chain antibodies against beta-amyloid peptide |
| 02/22/2007 | CA2619716A1 Antigenic peptides and their use |
| 02/22/2007 | CA2619245A1 Chimeric antibodies with new world primate regions |
| 02/22/2007 | CA2619244A1 Engineered antibodies with new world primate framework regions |
| 02/22/2007 | CA2618920A1 Human monoclonal antibodies that specifically bind igf-ii |
| 02/22/2007 | CA2617987A1 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit |
| 02/22/2007 | CA2611465A1 Improving antibody expression using vectors containing insulator elements |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754787A2 Methods for producing members of specific binding pairs |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754717A1 Antigenic peptides and their use |
| 02/21/2007 | EP1754715A1 Vaccine on the basis of virus-neutralising antibodies |
| 02/21/2007 | EP1754490A2 CD 154 blockage therapy for pancreatic islet tissue transplantation in primates |
| 02/21/2007 | EP1753880A2 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna |
| 02/21/2007 | EP1753875A2 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 02/21/2007 | EP1753874A1 Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis |
| 02/21/2007 | EP1753871A2 Antibodies and related molecules that bind to psca proteins |
| 02/21/2007 | EP1753783A2 Anti-cd3 antibodies and methods of use thereof |
| 02/21/2007 | EP1753507A1 Combination of radio waves and pharmacologically active substances |
| 02/21/2007 | EP1753465A1 Assay for transmissible spongiform encephalopathies |
| 02/21/2007 | EP1753463A2 Antibody drug conjugates and methods |
| 02/21/2007 | EP1753456A2 Methods for treating conditions associated with masp-2 dependent complement activation |
| 02/21/2007 | EP1753455A2 Method for treating multiple sclerosis |
| 02/21/2007 | EP1753404A1 Microspheres comprising protein and showing injectability at high concentrations of said agent |
| 02/21/2007 | EP1608685B1 Vegf antagonists for the treatment of diabetes |
| 02/21/2007 | EP1578955A4 Candida kefyr cytosine deaminase |
| 02/21/2007 | EP1534404B1 Use of a clathrate modifier to promote passage of proteins during nanofiltration |
| 02/21/2007 | EP1290137B1 Virulence genes, proteins, and their use |
| 02/21/2007 | EP1280545B1 Cross-linked collagen matrices and methods for their preparation |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1220687B1 Administration of gamma globulins to treat lymphoma |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1151307B1 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 02/21/2007 | EP1141366B1 Transfectacons comprising calcium phosphate and a nucleic acid |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1100819B1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/21/2007 | EP1075521B1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/21/2007 | EP0870014B1 Aldolase catalytic antibody |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0602046B2 Detection of feline immunodeficiency viruses |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918295A Method of reinforcing antibody activity |
| 02/21/2007 | CN1918181A Detection of cd20 in transplant rejection |
| 02/21/2007 | CN1918180A Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 02/21/2007 | CN1918179A Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell |
| 02/21/2007 | CN1918178A Fc region variants |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917901A Detection of cd20 in therapy of autoimmune diseases |
| 02/21/2007 | CN1916167A Modulation of peroxisome proliferation-activated receptors |
| 02/21/2007 | CN1916026A Polyclonal antibody of colibacillus, prepartioon method and appication |
| 02/21/2007 | CN1916019A Method for preparing CYP4A11 polypeptide, and antibody for anti human CYP4A11 polypeptide |
| 02/21/2007 | CN1915433A Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 02/20/2007 | US7179953 Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation |
| 02/20/2007 | US7179900 Novel nucleic acid molecules; immunospecifically binding respiratory syncytial virus (RSV) antigens; long half life; reduced dosage and side effects |
| 02/20/2007 | US7179899 Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72 |
| 02/20/2007 | US7179893 Recombinant anti-TNF-α antibodies |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179884 Polypeptides; proteolysis splitting; antitumor agents |
| 02/20/2007 | US7179785 Compounds that bind to p185 and methods of using the same |
| 02/20/2007 | US7179640 For detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179625 vectors, host cells, selective binding agents, such as antibodies, and methods for producing huE3 alpha polypeptides |
| 02/20/2007 | US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene |
| 02/20/2007 | US7179611 Purification; isoelectric precipitation; analyzing |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179606 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179605 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179603 Detection and identification of enteric bacteria |
| 02/20/2007 | US7179601 Methods of identifying plant disease-resistance genes |
| 02/20/2007 | US7179595 non-single-chain antigen-binding units that is stabilized by leucine zipper sequences; useful for generating and screening for non-single-chain antigen-binding units that remain the binding capabilities to their respective antigens within a cell of major diagnostic and/or therapeutic potential |
| 02/20/2007 | US7179470 Hepatitis-C virus testing |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179466 Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179464 Immunoglobulin for use in the treatment and prevention of asthma |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179448 Recombinant constructs of Borrelia burgdorferi |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2192512C Nm03 antibody materials and methods |
| 02/15/2007 | WO2007019541A2 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/15/2007 | WO2007019064A2 ANTI-TNFα ANTIBODIES AND METHODS OF USE |
| 02/15/2007 | WO2007018853A2 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | WO2007018556A2 Method for detection and decontamination of antigens by nanoparticle-raman spectroscopy |
| 02/15/2007 | WO2007018475A1 Novel anticoagulant polypeptides and complex |
| 02/15/2007 | WO2007018199A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018198A1 Cancer-rejection antigen peptide derived from hsp105 for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007017859A1 Intravenous immunoglobulin composition |